Vext Science, Inc. (VEXT.CN)
CAD 0.13
(0.0%)
CAD 0.13
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 4.39 Million USD | -59.72% |
| 2022 | 10.91 Million USD | 118.97% |
| 2021 | 4.98 Million USD | 134.66% |
| 2020 | 2.12 Million USD | -23.92% |
| 2019 | 2.79 Million USD | -25.48% |
| 2018 | 3.74 Million CAD | -8.73% |
| 2017 | 4.1 Million CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -4.39 Million USD | 30.37% |
| 2024 Q1 | -6.33 Million USD | -212.03% |
| 2023 Q3 | -1.83 Million USD | -443.3% |
| 2023 Q2 | 535.45 Thousand USD | 632.91% |
| 2023 Q4 | 5.62 Million USD | 406.18% |
| 2023 Q1 | 73.05 Thousand USD | -98.84% |
| 2023 FY | 4.39 Million USD | -59.72% |
| 2022 Q2 | 1.95 Million USD | -43.55% |
| 2022 Q1 | 3.45 Million USD | 218.71% |
| 2022 FY | 10.91 Million USD | 118.97% |
| 2022 Q3 | 423.53 Thousand USD | -78.3% |
| 2022 Q4 | 6.29 Million USD | 1385.21% |
| 2021 Q3 | 970.1 Thousand USD | -45.88% |
| 2021 Q2 | 1.79 Million USD | 57.36% |
| 2021 Q1 | 1.13 Million USD | 1.1% |
| 2021 FY | 4.98 Million USD | 134.66% |
| 2021 Q4 | 1.08 Million USD | 11.85% |
| 2020 FY | 2.12 Million USD | -23.92% |
| 2020 Q1 | -971.02 Thousand USD | -16.7% |
| 2020 Q4 | 1.12 Million USD | -20.26% |
| 2020 Q3 | 1.41 Million USD | 153.95% |
| 2020 Q2 | 556.39 Thousand USD | 157.3% |
| 2019 FY | 2.79 Million USD | -25.48% |
| 2019 Q2 | 1.17 Million USD | -29.03% |
| 2019 Q1 | 1.66 Million USD | 374.81% |
| 2019 Q4 | -832.08 Thousand USD | -206.01% |
| 2019 Q3 | 784.93 Thousand USD | -33.43% |
| 2018 Q2 | 975.83 Thousand USD | -8.8% |
| 2018 Q3 | 1.35 Million USD | 38.63% |
| 2018 Q4 | 349.91 Thousand USD | -74.13% |
| 2018 FY | 3.74 Million CAD | -8.73% |
| 2018 Q1 | 1.06 Million USD | 0.0% |
| 2017 FY | 4.1 Million CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Aion Therapeutic Inc. | -6.28 Million CAD | 169.959% |
| Ayurcann Holdings Corp. | -3.96 Million CAD | 210.855% |
| Blueberries Medical Corp. | -1.63 Million CAD | 368.957% |
| The BC Bud Corporation | -1.22 Million CAD | 459.334% |
| BioNxt Solutions Inc. | -7.72 Million CAD | 156.953% |
| CordovaCann Corp. | -6.88 Million CAD | 163.888% |
| Christina Lake Cannabis Corp. | -4.13 Million CAD | 206.453% |
| Captor Capital Corp. | -11.38 Million CAD | 138.647% |
| City View Green Holdings Inc. | -2.44 Million CAD | 279.632% |
| 1CM Inc. | -913.85 Thousand CAD | 581.306% |
| Global Hemp Group Inc. | -2.58 Million CAD | 270.447% |
| Greenway Greenhouse Cannabis Corporation | -4.72 Million CAD | 193.135% |
| IM Cannabis Corp. | -9.49 Million CAD | 146.309% |
| Lobe Sciences Ltd. | -4.7 Million CAD | 193.438% |
| Maple Leaf Green World Inc. | -1.09 Million CAD | 502.963% |
| Mountain Valley MD Holdings Inc. | -7.67 Million CAD | 157.346% |
| Nextleaf Solutions Ltd. | 223.33 Thousand CAD | -1869.448% |
| Ovation Science Inc. | -813.14 Thousand CAD | 640.915% |
| Pharmadrug Inc. | -13.2 Million CAD | 133.318% |
| Captiva Verde Wellness Corp. | -6.08 Million CAD | 172.282% |
| RAMM Pharma Corp. | -7.72 Million CAD | 156.968% |
| RIV Capital Inc. | -106.76 Million CAD | 104.12% |
| Revive Therapeutics Ltd. | -5.61 Million CAD | 178.283% |
| Red White & Bloom Brands Inc. | -138.89 Million CAD | 103.167% |
| SLANG Worldwide Inc. | -19.36 Million CAD | 122.712% |
| 1933 Industries Inc. | -13.36 Million CAD | 132.913% |
| Red Light Holland Corp. | -7.62 Million CAD | 157.667% |
| Top Strike Resources Corp. | -1.72 Million CAD | 355.719% |
| Xebra Brands Ltd. | -1.95 Million CAD | 324.711% |
| Adastra Holdings Ltd. | -3.54 Million CAD | 224.087% |